Variant report
Variant | rs3131863 |
---|---|
Chromosome Location | chr6:29673483-29673484 |
allele | C/T |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:5)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:5 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr6:29673244..29674572-chr6:29802335..29803091,3 | MCF-7 | breast: | |
2 | chr6:29673185..29674019-chr6:29806166..29806939,2 | MCF-7 | breast: | |
3 | chr6:29673438..29674041-chr6:30098583..30099284,2 | MCF-7 | breast: | |
4 | chr6:29673331..29674077-chr6:29980846..29981765,3 | K562 | blood: | |
5 | chr6:29617501..29618041-chr6:29673112..29673633,2 | K562 | blood: |
No data |
No data |
No data |
No data |
rs_ID | r2[population] |
---|---|
rs1476572 | 0.98[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes];0.99[ASN][1000 genomes] |
rs1476573 | 0.98[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs1610584 | 0.98[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs1610585 | 0.98[AFR][1000 genomes];1.00[AMR][1000 genomes];0.99[EUR][1000 genomes];0.99[ASN][1000 genomes] |
rs1610586 | 0.98[AFR][1000 genomes];1.00[AMR][1000 genomes];0.99[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs1610587 | 0.98[AFR][1000 genomes];1.00[AMR][1000 genomes];0.99[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs1610590 | 0.93[AFR][1000 genomes];0.93[AMR][1000 genomes];0.98[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs1610592 | 0.95[AFR][1000 genomes];1.00[AMR][1000 genomes];0.99[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs1610593 | 0.95[AFR][1000 genomes];1.00[AMR][1000 genomes];0.99[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs1610594 | 0.95[AFR][1000 genomes];1.00[AMR][1000 genomes];0.98[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs1610595 | 0.94[AFR][1000 genomes];1.00[AMR][1000 genomes];0.98[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs1610745 | 0.95[AFR][1000 genomes];1.00[AMR][1000 genomes];0.98[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs1611356 | 0.95[AFR][1000 genomes];1.00[AMR][1000 genomes];0.98[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs1611357 | 0.95[AFR][1000 genomes];1.00[AMR][1000 genomes];0.97[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs1611358 | 0.95[AFR][1000 genomes];1.00[AMR][1000 genomes];0.98[EUR][1000 genomes];0.99[ASN][1000 genomes] |
rs1611359 | 0.95[AFR][1000 genomes];0.99[AMR][1000 genomes];0.98[EUR][1000 genomes];0.99[ASN][1000 genomes] |
rs1611360 | 0.95[AFR][1000 genomes];0.99[AMR][1000 genomes];0.98[EUR][1000 genomes];0.99[ASN][1000 genomes] |
rs1611361 | 0.95[AFR][1000 genomes];0.99[AMR][1000 genomes];0.98[EUR][1000 genomes];0.99[ASN][1000 genomes] |
rs1611362 | 0.95[AFR][1000 genomes];0.99[AMR][1000 genomes];0.98[EUR][1000 genomes];0.99[ASN][1000 genomes] |
rs1611363 | 0.95[AFR][1000 genomes];0.97[AMR][1000 genomes];0.98[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs1611365 | 0.95[AFR][1000 genomes];0.97[AMR][1000 genomes];0.98[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs1611366 | 0.95[AFR][1000 genomes];0.97[AMR][1000 genomes];0.98[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs1611368 | 0.92[AFR][1000 genomes];0.97[AMR][1000 genomes];0.96[EUR][1000 genomes];0.99[ASN][1000 genomes] |
rs1611369 | 0.95[AFR][1000 genomes];0.97[AMR][1000 genomes];0.98[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs1611370 | 0.95[AFR][1000 genomes];0.97[AMR][1000 genomes];0.98[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs1611371 | 0.94[AFR][1000 genomes];0.82[AMR][1000 genomes] |
rs1611372 | 0.95[AFR][1000 genomes];0.97[AMR][1000 genomes];0.98[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs1611375 | 0.95[AFR][1000 genomes];0.97[AMR][1000 genomes];0.98[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs1611376 | 0.95[AFR][1000 genomes];0.97[AMR][1000 genomes];0.98[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs1611377 | 0.95[AFR][1000 genomes];0.97[AMR][1000 genomes];0.98[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs1611378 | 0.95[AFR][1000 genomes];0.97[AMR][1000 genomes];0.98[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs1611379 | 0.94[AFR][1000 genomes];0.96[AMR][1000 genomes];0.98[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs1611380 | 0.93[AFR][1000 genomes];0.82[AMR][1000 genomes] |
rs1627465 | 0.95[AFR][1000 genomes];0.96[AMR][1000 genomes];0.98[EUR][1000 genomes];0.98[ASN][1000 genomes] |
rs1633066 | 0.81[ASN][1000 genomes] |
rs1736913 | 0.84[ASN][1000 genomes] |
rs1736919 | 0.88[ASN][1000 genomes] |
rs1736930 | 0.95[AFR][1000 genomes];1.00[AMR][1000 genomes];0.98[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs1736931 | 0.95[AFR][1000 genomes];0.95[AMR][1000 genomes];0.96[EUR][1000 genomes];0.98[ASN][1000 genomes] |
rs1737069 | 0.80[ASN][1000 genomes] |
rs2394659 | 0.96[AFR][1000 genomes];0.93[AMR][1000 genomes];1.00[EUR][1000 genomes];0.98[ASN][1000 genomes] |
rs2394660 | 1.00[AFR][1000 genomes];0.95[AMR][1000 genomes];1.00[EUR][1000 genomes];0.98[ASN][1000 genomes] |
rs2394661 | 0.87[AFR][1000 genomes] |
rs2894114 | 1.00[AFR][1000 genomes];0.96[AMR][1000 genomes];1.00[EUR][1000 genomes];0.97[ASN][1000 genomes] |
rs3094726 | 1.00[AFR][1000 genomes];0.97[AMR][1000 genomes];0.99[EUR][1000 genomes];0.98[ASN][1000 genomes] |
rs3094727 | 0.95[EUR][1000 genomes];0.98[ASN][1000 genomes] |
rs3116788 | 0.98[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes];0.99[ASN][1000 genomes] |
rs3116789 | 0.98[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs3116790 | 1.00[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs3116791 | 1.00[AFR][1000 genomes];0.99[AMR][1000 genomes];1.00[EUR][1000 genomes];0.98[ASN][1000 genomes] |
rs3116792 | 1.00[AFR][1000 genomes];0.99[AMR][1000 genomes];1.00[EUR][1000 genomes];0.98[ASN][1000 genomes] |
rs3116793 | 1.00[AFR][1000 genomes];0.97[AMR][1000 genomes];0.99[EUR][1000 genomes];0.98[ASN][1000 genomes] |
rs3116794 | 1.00[AFR][1000 genomes];0.95[AMR][1000 genomes];0.99[EUR][1000 genomes];0.99[ASN][1000 genomes] |
rs3116795 | 0.98[AFR][1000 genomes];0.94[AMR][1000 genomes];1.00[EUR][1000 genomes];0.97[ASN][1000 genomes] |
rs3116796 | 1.00[AFR][1000 genomes];0.96[AMR][1000 genomes];1.00[EUR][1000 genomes];0.99[ASN][1000 genomes] |
rs3116797 | 0.93[EUR][1000 genomes];0.96[ASN][1000 genomes] |
rs3129052 | 0.85[ASN][1000 genomes] |
rs3131869 | 0.85[ASN][1000 genomes] |
rs3757324 | 0.80[ASN][1000 genomes] |
rs3757325 | 0.80[ASN][1000 genomes] |
rs3757326 | 0.80[ASN][1000 genomes] |
rs4711196 | 0.84[ASN][1000 genomes] |
rs7739360 | 0.87[ASN][1000 genomes] |
rs7739388 | 0.87[ASN][1000 genomes] |
rs7759272 | 0.87[ASN][1000 genomes] |
rs9258156 | 0.87[ASN][1000 genomes] |
rs9258163 | 0.80[ASN][1000 genomes] |
rs9258164 | 0.80[ASN][1000 genomes] |
rs9258166 | 0.80[ASN][1000 genomes] |
rs9258167 | 0.80[ASN][1000 genomes] |
rs9258168 | 0.80[ASN][1000 genomes] |
rs9258169 | 0.80[ASN][1000 genomes] |
rs9258170 | 0.80[ASN][1000 genomes] |
rs9258171 | 0.80[ASN][1000 genomes] |
rs9258172 | 0.80[ASN][1000 genomes] |
rs9258173 | 0.80[ASN][1000 genomes] |
rs9258174 | 0.80[ASN][1000 genomes] |
rs9258175 | 0.80[ASN][1000 genomes] |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | nsv883530 | chr6:29645038-29677641 | Weak transcription Bivalent/Poised TSS Flanking Active TSS Enhancers Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Genic enhancers ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNA | 5 gene(s) | inside rSNPs | diseases |
2 | esv20940 | chr6:29653954-29923410 | Flanking Active TSS Strong transcription Flanking Bivalent TSS/Enh Active TSS Weak transcription Enhancers Transcr. at gene 5' and 3' Bivalent Enhancer Genic enhancers Bivalent/Poised TSS ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 46 gene(s) | inside rSNPs | diseases |
3 | nsv970675 | chr6:29657036-29692268 | Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers Weak transcription Transcr. at gene 5' and 3' Genic enhancers | TF binding regionCpG islandChromatin interactive regionlncRNA | 8 gene(s) | inside rSNPs | diseases |
4 | nsv428475 | chr6:29659525-29763392 | Strong transcription Weak transcription Flanking Active TSS Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Genic enhancers Bivalent/Poised TSS Transcr. at gene 5' and 3' ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNA | 27 gene(s) | inside rSNPs | diseases |
5 | nsv428139 | chr6:29659525-29892317 | Bivalent Enhancer Active TSS Enhancers Flanking Active TSS Bivalent/Poised TSS Weak transcription Strong transcription Flanking Bivalent TSS/Enh Genic enhancers ZNF genes & repeats Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNA | 41 gene(s) | inside rSNPs | diseases |
6 | nsv427749 | chr6:29659525-29975144 | Enhancers Active TSS Strong transcription Flanking Active TSS ZNF genes & repeats Flanking Bivalent TSS/Enh Weak transcription Bivalent/Poised TSS Genic enhancers Bivalent Enhancer Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 53 gene(s) | inside rSNPs | diseases |
7 | nsv508397 | chr6:29663132-29761448 | Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Weak transcription Strong transcription Transcr. at gene 5' and 3' Enhancers Bivalent/Poised TSS Bivalent Enhancer Genic enhancers ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNA | 26 gene(s) | inside rSNPs | diseases |
8 | nsv519888 | chr6:29668537-29673483 | Enhancers Weak transcription Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh | Chromatin interactive region | n/a | inside rSNPs | diseases |
9 | esv1821077 | chr6:29670915-29726207 | Flanking Bivalent TSS/Enh Weak transcription Active TSS Bivalent/Poised TSS Bivalent Enhancer Enhancers Flanking Active TSS Transcr. at gene 5' and 3' Strong transcription Genic enhancers ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNA | 23 gene(s) | inside rSNPs | diseases |
10 | esv1794141 | chr6:29670915-29765814 | Enhancers Flanking Active TSS Active TSS Weak transcription Strong transcription Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Genic enhancers Transcr. at gene 5' and 3' ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNA | 28 gene(s) | inside rSNPs | diseases |
SNP | Gene | Cis/trans | Tissue | Source |
---|---|---|---|---|
rs3131863 | ZKSCAN3 | cis | cerebellum | SCAN |
rs3131863 | HLA-H | cis | lymphoblastoid | seeQTL |
rs3131863 | HLA-F | cis | multi-tissue | Pritchard |
rs3131863 | ZNF323 | cis | parietal | SCAN |
rs3131863 | HLA-F | cis | lymphoblastoid | seeQTL |
rs3131863 | BTN2A1 | cis | cerebellum | SCAN |
rs3131863 | ZKSCAN3 | cis | parietal | SCAN |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:29664000-29690600 | Weak transcription | Right Atrium | heart |
2 | chr6:29670200-29678200 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
3 | chr6:29670800-29673600 | Weak transcription | Liver | Liver |
4 | chr6:29670800-29678200 | Weak transcription | iPS DF 6.9 Cell Line | embryonic stem cell |
5 | chr6:29673200-29675800 | Enhancers | Primary T helper naive cells from peripheral blood | blood |
6 | chr6:29673200-29676200 | Enhancers | Primary T helper 17 cells PMA-I stimulated | -- |
7 | chr6:29673200-29676400 | Enhancers | Primary Natural Killer cells fromperipheralblood | blood |
8 | chr6:29673200-29677000 | Enhancers | Primary T helper naive cells fromperipheralblood | blood |
9 | chr6:29673400-29673800 | Enhancers | HUES6 Cell Line | embryonic stem cell |
10 | chr6:29673400-29676000 | Enhancers | Primary T cells fromperipheralblood | blood |
11 | chr6:29673400-29676200 | Enhancers | Primary T helper cells PMA-I stimulated | -- |
12 | chr6:29673400-29676200 | Enhancers | Primary T killer naive cells fromperipheralblood | blood |
13 | chr6:29673400-29676400 | Enhancers | Primary T helper cells fromperipheralblood | blood |
14 | chr6:29673400-29678600 | Weak transcription | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |